电驱动道路车辆动力锂离子电池系统气候环境试验和要求

本文是电驱动道路车辆动力锂离子电池的试验和要求标题下的气候环境部分,结合国标转化过程和实验室能力验证经历,将气候试验方法和要求作描述和解释,供实验室和相关产品的供需双方参考.     

路面标线用玻璃珠测试技术现状及其趋势

基于对国内外主要路面标线用玻璃珠标准的分析,论述了影响路面标线用玻璃珠质量的技术指标的相关测试技术,同时分类说明了不同测试技术发展的趋势。结果表明：路面标线用玻璃珠测试技术主要围绕外观质量、成圆率、粒径分布等11类性能指标展开,其中外观质量、粒径分布、折射率、耐蚀性为主要关注项目;耐水性等成熟的测试技术在各类标准中的相关技术内容基本相同;外观质量、成圆率、粒径分布3项测试技术的未来的研究方向是利用体视学的方法对其进行综合测试;用二次彩虹法替代浸油法是路面标线用玻璃珠折射率测试的发展方向,该方法研究的关键技术点在于光源的选择和如何将玻璃珠显现的二次彩虹影像准确、快速、定量地转换为折射率信息;新型涂层测试技术的深入研究、重金属测试方法的优选、玻璃珠组合型逆反射颗粒的测试参数的选取等相关工作需要进一步加强。     

工业探伤机在野外作业中的辐射防护距离探讨

从技术角度对工业探伤机在野外作业中的辐射防护距离进行了探讨,为探伤企业在工业探伤机野外作业的辐射防护距离提出了更加合理、可行的解决办法。     

遂昌金矿通风系统测定及评价

介绍了遂昌金矿通风系统的现状及测定结果，找出了该系统存在的问题，并提出相应的改进措施。     

Fetal aortic root dilation: a prenatal feature of the Loeys-Dietz syndrome

Loeys-Dietz syndrome is a recently described autosomal dominant disorder with cardinal manifestations in cardiovascular, craniofacial and skeletal systems. Although the disease has some phenotypic overlap with Marfan syndrome, the disease, that is caused by mutations in the transforming growth factor beta-receptor 1 (TGFBR1) or transforming growth factor beta-receptor 2 (TGFBR2) genes, presents many distinctive features and a particularly aggressive cardiovascular course. We describe prenatal identification of an aortic root aneurysm in a fetus of 19 week of gestation as an early marker of Loeys-Dietz syndrome. Copyright © 2006 John Wiley & Sons, Ltd.     

The efficacy of maternal age screening for Down's syndrome in Wessex

The uptake of amniocentesis in Wessex for the period 1986–1988 was 36 per cent (2873 of 8004 births), a proportion that has not altered significantly since 1984. There is a large difference in uptake between women in the lower risk age group, 35–36 years, and those in the higher risk group, 37 + years, and very considerable differences in uptake among different districts. The prenatal detection over the 3-year study period for women aged 35 or more, after correction for spontaneous loss of Down's syndrome fetuses between prenatal detection and birth, is 53 per cent, a figure that must be inflated due to our failure to ascertain all liveborn Down's syndrome patients.     

Prenatal diagnosis of severe osteogenesis imperfecta

The ultrasound findings in a series of 15 prenatally diagnosed cases of severe osteogenesis imperfecta types IIA, IIB, IIC, and III are described, eleven being detected on routine scans of women with no relevant history. As most cases of osteogenesis imperfecta type IIA are dominant sporadic mutations, the importance of prenatal diagnosis during routine scanning at a local level is emphasized. In addition to characteristic broad, shortened and fractured long bones, striking features of the chest and head are highlighted which may be encountered during a routine scan, prompting further assessment.     

A comparison of total and free β-HCG assays in Down syndrome screening

Free β-HCG is a new analyte that has been suggested to be superior to total HCG when used in combination with alpha-fetoprotein (AFP) for Down syndrome risk screening in early pregnancy. We have evaluated this claim on 21 samples collected from Down syndrome pregnancies and 180 samples from unaffected pregnancies. The detection rates for the combination of AFP with free β-HCG or the combination of AFP with total HCG were identical (71 per cent) but the initial screen positive rate (equivalent to the false-positive rate) was 7·5 per cent for AFP+free β-HCG screening compared with 3·5 per cent for AFP+ total HCG screening. We conclude that the case for free β-HCG is unproven and suggest that further data be collected before free β-HCG becomes acceptable.     

Appearance of excessive lipids in amniotic fluid as a sign of fetal hyperlipidaemia

The appearance of excessive lipids in amniotic fluid during Caesarean section raised the suspicion of a hyperlipidaemic fetus. The amniotic fluid had elevated cholesterol (53 mg/dl) and triglycerides (81 mg/dl). At the age of 2 months, the infant was hyperlipidaemic (cholesterol of 161 mg/dl and triglycerides of 84 mg/dl). The case suggests the possibility of prenatal diagnosis of hyperlipidaemia, a major risk factor for atherosclerosis.     

Cytogenetic experience in prenatal fra(X) detection on amniotic fluid cultures

Since 1987, we have had experience with 13 prenatal diagnoses of 11 women at risk for the fragile X syndrome by cytogenetic studies on amniotic fluid cultures. The induction method included TC 199 medium and methotrexate. Results were obtained in all cases. Ten were males and three were prenatally diagnosed as being affected. Three were females and none of them was fra(X)-positive. Results were confirmed in 10/13 cases. In these cases, we had neither false-positive nor false-negative results.